ARCHIVES

Group Chairmen Accept Most Changes In Terms Of Award, Object To CTEP Adjustments

This article is from The Cancer Letter archive.

Vol. 14 No. 47 | December 2, 1988

Download PDF Visit The Full Archive

Related Articles

Gleevec Maintenance Therapy Showed Significant Benefits At Three Years in Phase III Trial

April 27, 2012

Administration Asking $233 Million Less For NCI In FY ’88 Than Congress Is Appropriating For ‘87

October 10, 1986

AIDS Commission Asks, “Give Us A Chance”

September 18, 1987

House Passes Cancer Bill With Mandates for NCI

September 28, 2012

Senate Approves Supplemental Funds For NIH and FDA.

May 23, 2008

In Brief: US Pharmacopeia Names Advisory Panel For Hematologic And Oncological Disease

May 31, 1996